The HCMV Chemokine Receptor US28 is a Potential Target in Vascular Disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-5852|1|2|151-158

ISSN： 1568-0053

Source： Current Drug Targets - Infectious Disorders, Vol.1, Iss.2, 2001-08, pp. : 151-158

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Human Cytomegalovirus US28: A Functionally Selective Chemokine Binding Receptor

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 9, Iss. 5, 2009-10 ,pp. : 548-556

Bentham Science Publishers

Access to resources Recommend Favorite

Dysregulated Chemokine Signaling in Cystic Fibrosis Lung Disease: A Potential Therapeutic Target

By  

Current Drug Targets, Vol. 17, Iss. 13, 2016-09 ,pp. : 1535-1544

Bentham Science Publishers

Access to resources Recommend Favorite

Is Bilirubin a Marker of Vascular Disease and/or Cancer and is it a Potential Therapeutic Target?

By  

Current Pharmaceutical Design, Vol. 17, Iss. 33, 2011-11 ,pp. : 3644-3655

Bentham Science Publishers

Access to resources Recommend Favorite

P2Y Purinoceptors as Potential Emerging Therapeutical Target in Vascular Disease

By  

Current Pharmaceutical Design, Vol. 18, Iss. 37, 2012-12 ,pp. : 6169-6180

Bentham Science Publishers

Access to resources Recommend Favorite

The Chemokine Receptor CXCR4 as a Therapeutic Target for Several Diseases

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 9, 2006-09 ,pp. : 989-995

Bentham Science Publishers

Access to resources Recommend Favorite